- Company: Lupin Pharmaceuticals, Inc.
- Product: Thiamine Hydrochloride Injection USP
- Indication: Treatment of thiamine deficiency
- Formulation: 100 mg/mL single-dose vial
- Availability: By prescription only
- Manufactured: At Lupin’s facility in Goa, India
The launch of Thiamine Hydrochloride Injection USP is a significant development for Lupin. The product is the first generic thiamine injection to be launched in the US in over 20 years. The launch is expected to help Lupin expand its presence in the US generic injectables market.
Thiamine Hydrochloride Injection USP is a prescription medication used to treat thiamine deficiency, which can lead to beriberi, a serious condition that can cause nerve damage, heart problems, and other health problems. Thiamine is an essential vitamin that is needed for the body to function properly.
The product is available in a 100 mg/mL single-dose vial. It is indicated for the treatment of thiamine deficiency. The product is available by prescription only. The product is manufactured at Lupin’s facility in Goa, India.
The launch of Thiamine Hydrochloride Injection USP is expected to help Lupin expand its presence in the US generic injectables market. The product is the first generic thiamine injection to be launched in the US in over 20 years. This launch is expected to increase competition in the market and could lead to lower prices for consumers.
The launch of Thiamine Hydrochloride Injection USP is also a significant development for patients with thiamine deficiency. The product offers a new and affordable option for treatment.